Cancer Waiting Times Analysis - OG Linda Wintersgill 12/11/2014

Activity Trend NESCN - Upper GI Cancer Activity Trend (Provider based) 14000 13084 2WW 31D 62D 12000 11515 10164 10000 9417 8727 8000 6000 4000 2000 1308 1297 1298 1264 1285 596 579.5 525 530.5 539 0 2009/10 2010/11 2011/12 2012/13 2013/14 2

2WW Referrals – Upper GI NESCN 2WW Upper GI Referrals (Q1 2009- Q4 2014) 2WW Referrals 4500 4000 3500 3000 2500 Upper GI 2WW NESCN Performance/Operational Performance (Q1 2009- Q4 2014) 2000 2WW Performance Operational Target 96 1500 95 94 1000 93 500 92 91 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 90 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14 89 88 87 3 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14

31 Days – Upper GI NESCN 31D Upper GI First Treatments (Q1 2009- Q4 2014) 31D First Treatments 400 350 300 250 Upper GI 31D NESCN Performance/Operational Performance (Q1 2009- Q4 2014) 200 31D Performance Operational Target 100 150 99 100 98 50 97 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 96 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14 95 94 4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14

62 Days – Upper GI NESCN 62D Upper GI Referrals (Q1 2009- Q4 2014) 62D Referrals 180 160 140 120 100 Upper GI 62D NESCN Performance/Operational Performance (Q1 2009- Q4 2014) 90 62D Performance Operational Performance 80 85 60 80 40 20 75 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 70 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14 5 65 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 09/10 09/10 09/10 09/10 10/11 10/11 10/11 10/11 11/12 11/12 11/12 11/12 12/13 12/13 12/13 12/13 13/14 13/14 13/14 13/14

Referral – First Seen - All NESCN - Cancer Waits - Median Wait Times - Referral to First Seen (2WW) Referrals - Diagnosed OG Cancer Patients 14 2009/10 2010/11 2011/12 2012/13 2013/14 12 10 8 6 4 2 10 10 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 6

First Seen – Decision to Treat - All NESCN - Cancer Waits - Median Wait Times - First Seen to DTT (62D) OG Cancer 60 2009/10 2010/11 2011/12 2012/13 2013/14 50 40 30 20 10 31 39 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 7

DTT – First Treatment - All NESCN - Cancer Waits - Median Wait Times - DTT to First Treatment (31D) OG Cancer 12 2009/10 2010/11 2011/12 2012/13 2013/14 10 8 6 4 2 0 0 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 8

Referral – First Treatment - All NESCN - Cancer Waits - Median Waits - Referral to First Treatment (62D) OG Cancer 70 2009/10 2010/11 2011/12 2012/13 2013/14 60 50 40 30 20 10 50 59 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 9

Pathway Length by Treatment Group NESCN - Cancer Waits - Median Wait Referral to First Treatment OG Cancer 70.0 60.0 50.0 40.0 30.0 20.0 10.0 All Surg Drugs Rty Pall Other 0.0 2009/10 2010/11 2011/12 2012/13 2013/14 10

SURGICAL TREATMENTS 11

Referral – First Seen – Surgery NESCN - Cancer Waits - Median Wait Times - Referral to First Seen (2WW) Referrals - Diagnosed OG Cancer Patients - Surgical Treatments 16 2009/10 2010/11 2011/12 2012/13 2013/14 14 12 10 8 6 4 2 10 11 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 12

First Seen – DTT - Surgery NESCN - Cancer Waits - Median Wait Times - First Seen to DTT (62D) OG Cancer - Surgical Treatments 50 2009/10 2010/11 2011/12 2012/13 2013/14 45 40 35 30 25 20 15 10 5 31 35 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 13

DTT – First Treatment - Surgery NESCN - Cancer Waits - Median Wait Times - DTT to First Treatment (31D) OG Cancer - Surgical Treatments 12 2009/10 2010/11 2011/12 2012/13 2013/14 10 8 6 4 2 0 3 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 14

Referral – First Treatment - Surgery NESCN - Cancer Waits - Median Waits - Referral to First Treatment (62D) OG Cancer - Surgical Patients 70 2009/10 2010/11 2011/12 2012/13 2013/14 60 50 40 30 20 10 50 51 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 15

DRUGS TREATMENTS 16

Referral – First Seen – Drugs NESCN - Cancer Waits - Median Wait Times - Referral to First Seen (2WW) Referrals - Diagnosed OG Cancer Patients - Drugs Treatments 16 2009/10 2010/11 2011/12 2012/13 2013/14 14 12 10 8 6 4 2 10 10 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 17

First Seen – DTT - Drugs NESCN - Cancer Waits - Median Wait Times - First Seen to DTT (62D) OG Cancer Patients - Drugs Treatments 70 2009/10 2010/11 2011/12 2012/13 2013/14 60 50 40 30 20 10 36 39 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 18

DTT – First Treatment - Drugs NESCN - Cancer Waits - Median Wait Times - DTT - First Treatment (31D) OG Cancer Patients - Drugs Treatments 25 2009/10 2010/11 2011/12 2012/13 2013/14 20 15 10 5 13 9 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 19

Referral – First Treatment - Drugs NESCN - Cancer Waits - Median Wait Times - Referral to Treatment (62D) OG Cancer Patients - Drugs Treatments 90 2009/10 2010/11 2011/12 2012/13 2013/14 80 70 60 50 40 30 20 10 57 61 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 20

RADIOTHERAPY TREATMENTS 21

Referral – First Seen – Radiotherapy NESCN - Cancer Waits - Median Wait Times - Referral to First Seen (2WW) Referrals - Diagnosed OG Cancer Patients - Radiotherapy Treatments 14 2009/10 2010/11 2011/12 2012/13 2013/14 12 10 8 6 4 2 10 10 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 22

First Seen – DTT - Radiotherapy NESCN - Cancer Waits - Median Wait Times - First Seen to DTT (62D) OG Cancer - Radiotherapy Treatments 60 2009/10 2010/11 2011/12 2012/13 2013/14 50 40 30 20 10 35 43 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 23

DTT – First Treatment : Radiotherapy NESCN - Cancer Waits - Median Wait Times - DTT to First Treatment (31D) OG Cancer - Radiotherapy Treatments 30 2009/10 2010/11 2011/12 2012/13 2013/14 25 20 15 10 5 14 11 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 24

Referral – First Treatment - Radiotherapy NESCN - Cancer Waits - Median Wait Times - Referral- First Treatment (62D) OG Cancer - Radiotherapy Treatments 80 2009/10 2010/11 2011/12 2012/13 2013/14 70 60 50 40 30 20 10 58 61 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 25

PALLIATIVE TREATMENTS 26

Referral – First Seen – Palliative NESCN - Cancer Waits - Median Wait Times - Referral to First Seen (2WW) Referrals - Diagnosed OG Cancer Patients - Palliative Treatments 16 2009/10 2010/11 2011/12 2012/13 2013/14 14 12 10 8 6 4 2 11 9 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 27

First Seen – DTT - Palliative NESCN - Cancer Waits - Median Wait Times - First Seen to DTT (62D) OG Cancer - Palliative Treatments 60 2009/10 2010/11 2011/12 2012/13 2013/14 50 40 30 20 10 25 31 0 South Tyneside Gateshead Northumbria Newcastle South Tees CDDFT North Tees & Sunderland N Cumbria NESCN Hartlepool 28

Cancer Waiting Times Analysis - OG Linda Wintersgill 12/11/2014 - PowerPoint PPT Presentation

Cancer Waiting Times Analysis - OG Linda Wintersgill 12/11/2014 Activity Trend NESCN - Upper GI Cancer Activity Trend (Provider based) 14000 13084 2WW 31D 62D 12000 11515 10164 10000 9417 8727 8000 6000 4000 2000 1308 1297

Advent: a season of waiting Waiting Not a popular pastime Waiting through the barren times

Waiting times for Prison mental health hospital transfer and remission Analysis of NHS England

Managing Waiting Lines NKFUST The Economies of Waiting Features of Queuing Systems

Managing Waiting Lines NKFUST The Economies of Waiting Features of Queuing Systems

Emma Wheatfill Cancer Services Manager Reduce number of outpatient visits Reduce waiting

Waiting Times in BMAP/BMAP/1 Queues MAM-9, Budapest Nail Akar, Bilkent University, Ankara, Turkey

Waiting Times: Performance, Improvement and Sustainability @nhsscotlandevent #NHSScot19

Our Performance Waiting Times Despite continuing high numbers of referrals in the

Chapter 8 Variability and Waiting Time Problems A Call Center Example Arrival Process and

What might help reduce waiting times in CAMHS? Bill Williams, General Manager and IAPT Project

WAITING.... In the waiting room How Long, O Lord Psalm 83:1 O God, do not keep silence; do not

Managing Waiting Lines NKFUST The Economies of Waiting Features of Queuing Systems

BREAST CANCER DATA ANALYSIS SAIF UR-REHMAN CANCER INFORMATICS BREAKTHROUGH BREAST CANCER

Cancer gene discovery via network analysis of somatic mutation data Insuk Lee Cancer is a

Context 31,000 people reported seen by AOD services in 2010 76% (205/267) NGOs reporting

Cancer Genome Analysis 02-715 Advanced Topics in Computa8onal Genomics

Pathway Analysis Jenny Wu Outline Introduction to NGS data analysis in Cancer Genomics

Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene

Whole genome analysis to support cancer treatment decision making: The BC Cancer Agency

The Cost of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of

COCHIN-TIMES: Integra3on of Vehicle Consumer Choice in TIMES

Global burden of cancer between 1990 and 2010 Preliminary results from a systematic analysis and

TIMES TABLES HOW WE TEACH TIMES TABLES AND HOW YOU CAN HELP WHY ARE TIMES TABLES IMPORTANT?

Cancer Genome Analysis (CONEXIC) Akavia et al. Cell, 2010. 02-715